Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.59
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
88
89
Next >
If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,200 Today
December 01, 2023
Via
Benzinga
Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient
November 30, 2023
Novo Nordisk A/S (NYSE: NVO) has reportedly taken legal action against Florida compounding pharmacies, suing one and refiling a lawsuit against another, as it discovered impurities in their products...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
November 30, 2023
Electronic health records say tirzepatide, the active ingredient in Mounjaro and Zepbound, is better at reducing weight than semaglutide, the active ingredient in Ozempic and Wegovy.
Via
The Motley Fool
Counterfeit Ozempic Raises Alarms - Lebanon Reports Hypoglycemia Cases
November 29, 2023
Lebanese health officials have reported eleven cases of severe hypoglycemia linked to suspected fake versions of Novo Nordisk A/S's (NYSE: NVO)
Via
Benzinga
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
November 29, 2023
Real-world data showed some real-world advantages for Ozempic's top rival.
Via
The Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
November 28, 2023
Via
Benzinga
Elliott Wave Technical Analysis: Eli Lilly & Co.
November 28, 2023
Looking for a triangle in wave (b) as we seem to be near the end of the correction.
Via
Talk Markets
$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today
November 22, 2023
Via
Benzinga
The Best Stocks to Invest $5,000 in Right Now
November 22, 2023
Here's how to safeguard your money and grow richer.
Via
The Motley Fool
Lilly's Weight-Loss Drug Wallops Novo's In Head-To-Head Study; Novo Stock Dives
November 28, 2023
The study examined health care records for more than 41,000 people.
Via
Investor's Business Daily
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
November 28, 2023
A recent extensive analysis by Truveta Research has
Via
Benzinga
Biotech And Healthcare Portfolio Playbook For December 2023/24
November 27, 2023
We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.
Via
Talk Markets
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
November 27, 2023
Novo Nordisk A/S (NYSE: NVO) is reportedly discussing with healthcare systems to introduce innovative pricing arrangements for its popular weight
Via
Benzinga
3 Top Stocks That'll Make Smart Investors Rich
November 27, 2023
Long-term investing is one possible path to riches.
Via
The Motley Fool
Uncovering Noteworthy Technical Analysis Findings for ELI LILLY & CO (NYSE:LLY).
November 21, 2023
Promising Signs: ELI LILLY & CO Setting the Stage for a Breakout.
Via
Chartmill
Analyst Expectations for Eli Lilly's Future
November 20, 2023
Via
Benzinga
A Look Into Eli Lilly Inc's Price Over Earnings
November 20, 2023
Via
Benzinga
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
November 26, 2023
An upcoming mid-stage readout may not spark a trend reversal in the big pharma's shares.
Via
The Motley Fool
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
November 26, 2023
There's no time like the present to buy these stocks.
Via
The Motley Fool
Google Leads Five S&P 500 Stocks Near Buy Points
November 25, 2023
Four of the stocks tripped up after earnings, but quickly bounced back.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Could Ozempic Harm These 3 Medical Device Stocks?
November 25, 2023
The drug is on track to cause massive competitive shifts in the healthcare sector.
Via
The Motley Fool
$3,000 Invested in These 3 Top Stocks Could Make You Rich in 10 Years
November 23, 2023
Plug into a trio of megatrends with these three particular tickers.
Via
The Motley Fool
Will Eli Lilly Be Worth More Than Tesla by 2027?
November 23, 2023
It's a lot more likely than it sounds.
Via
The Motley Fool
3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape
November 22, 2023
Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.
Via
InvestorPlace
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
November 22, 2023
Could AstraZeneca be an under-rated buy right now?
Via
The Motley Fool
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this
Via
Benzinga
Magnificent 7 Take Center Stage In Hedge Fund Portfolios: Analysts Warn Of Extreme Concentration
November 21, 2023
Hedge fund portfolios are intensifying their focus on technology stocks, with holdings in mega-cap tech reaching record levels.
Via
Benzinga
Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?
November 21, 2023
New class of weight-reducing drugs underpin launch of exchange-traded fundTema launches healthcare ETF focused on companies researching and treating cardiovascular disease, obesity and diabetes,...
Via
Benzinga
Topics
ETFs
Ignore Eli Lilly. These 2 Stocks Are Better Buys Right Now
November 21, 2023
Investors have favored an exciting billion-dollar opportunity at Eli Lilly.
Via
The Motley Fool
Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?
November 19, 2023
Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.
Via
The Motley Fool
Exposures
Product Safety
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
88
89
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.